Citation Impact
Citing Papers
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
Palliative Care Consultation Teams Cut Hospital Costs For Medicaid Beneficiaries
2011
First-line chemotherapy for NSCLC: an overview of relevant trials
2002
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
An epigenetic mechanism for capecitabine resistance in mesothelioma
2009
Generalist plus Specialist Palliative Care — Creating a More Sustainable Model
2013 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Role of Gemcitabine in Breast Cancer Management: An Update
2006
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
1998
Cancer drug resistance: an evolving paradigm
2013 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Esophageal Cancer
2003 Standout
Anthrazykline in der Krebstherapie
1997 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Photodynamic therapy for cancer
2003 Standout
Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy
2008
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
2002
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens
2001
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Advances in the Treatment of Malignant Pleural Mesothelioma
1999
Evaluation of Firefly Luciferase Bioluminescence Mediated Photodynamic Toxicity in Cancer Cells
2006
Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy
1992 Standout
Measuring quality of life in cancer patients.
1989
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
1995
Chemotherapy for Malignant Pleural Mesothelioma
2003
Malignant pleural mesothelioma
1998
Kasabach-Merritt syndrome
1988
A review of peritoneal mesothelioma at the Washington Cancer Institute
2003
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment
2008 Standout
A Review of Chemotherapy Trials for Malignant Mesothelioma
1998
The Role of Chemotherapy at the End of Life
2008
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
1993 Standout
Technique of Photodynamic Therapy for Disseminated Intraperitoneal Malignant Neoplasms
1991
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
2002
Advances in Malignant Mesothelioma
2005 Standout
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Clinical PD/PDT in North America: An historical review
2004
Photodynamic Therapy
1999
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
1989
Association Between Palliative Care and Patient and Caregiver Outcomes
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
1999
Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project
1999
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
2003
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
2000
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Dual mode of cell death upon the photo-irradiation of a RuIIpolypyridyl complex in interphase or mitosis
2016
Chemotherapy of advanced non-small cell lung cancer
1999
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Nanoparticles in Photodynamic Therapy
2015 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS
1987
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
BODIPY dyes in photodynamic therapy
2012 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
The History of Photodetection and Photodynamic Therapy¶
2001
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Reversible Photochemical Control of Singlet Oxygen Generation Using Diarylethene Photochromic Switches
2014 StandoutNobel
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast.
1987
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Photodynamic Therapy in Oncology
2006
Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy
1995 Standout
A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma
1996
Second-line chemotherapy for non-small cell lung cancer
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Ralph W. Roach being referenced
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
2001
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial
2001
A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study
1988
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.
1993
Development and Implementation of an Inpatient Acute Palliative Care Service
2002
Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer.
1987
A comparison of mitoxantrone and doxorubicin in breast cancer.
1986
Palliation of esophageal malignancy with photoradiation therapy
1984
Successful treatment of skeletal hemangioma and kasabach-merritt syndrome with aminocaproic acid
1982